Address https://gelex.eu/eli/EU/regulation/2011/213@2011-03-03/en

Contents

1. Preamble
2. 1. Article 1
   2. Article 2
3. ANNEX
4. ANNEX
5. 1. —

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Directive 2005/36/EC of the European Parliament and of the Council of 7 September 2005 on the recognition of professional qualifications, and in particular the second paragraph of Article 11 and the second paragraph of Article 26,

Whereas:

(1) Austria has requested the insertion in Annex II to Directive 2005/36/EC of 10 training programmes related to healthcare. These training programmes are regulated by the Healthcare and Nursing Special Task Ordinance (GuK-SV BGBl II No 452/2005) and the Healthcare and Nursing Teaching and Management Duties Ordinance (GuK-LFV BGBl II No 453/2005).

(2) As these Austrian training programmes are of an equivalent level of training to that provided for under Article 11(c)(i) of Directive 2005/36/EC and provide a comparable professional standard and prepare the trainee for a comparable level of responsibilities and functions, their inclusion on the basis of Article 11(c)(ii) in Annex II to Directive 2005/36/EC is justified.

(3) Portugal has submitted a reasoned request to include in point 5.1.3 of Annex V to Directive 2005/36/EC specialist medical training in medical oncology.

(4) Medical oncology aims at offering a systemic treatment of cancer. The treatment of cancer patients has undergone major changes over the last decade due to scientific progress. Specialist medical training in medical oncology is not listed in point 5.1.3 of Annex V to Directive 2005/36/EC. However, medical oncology has developed into a separate and distinct specialist medical training in more than two fifths of the Member States, which justifies its inclusion into point 5.1.3 of Annex V to Directive 2005/36/EC.

(5) In order to ensure a sufficiently high level of specialist medical training, the minimum period of training required for the medical specialty of medical oncology to be automatically recognised should be five years.

(6) France has submitted a reasoned request to include in point 5.1.3 of Annex V to Directive 2005/36/EC specialist medical training in medical genetics.

(7) Medical genetics is a specialty that responds to the rapid development of knowledge in the field of genetics and its implication in numerous specialised fields, such as oncology, foetal medicine, paediatrics, chronic diseases. Medical genetics plays a growing role in screening and in the prevention of numerous pathologies. Specialist medical training in medical genetics is not listed in point 5.1.3 of Annex V to Directive 2005/36/EC. However, it has developed into a separate and distinct specialist medical training in more than two fifths of the Member States, which justifies its inclusion into point 5.1.3 of Annex V to Directive 2005/36/EC.

(8) In order to ensure a sufficiently high level of specialist medical training, the minimum period of training required for the medical specialty of medical genetics to be automatically recognised should be four years.

(9) Directive 2005/36/EC should therefore be amended accordingly.

(10) The measures provided for in this Regulation are in accordance with the opinion of the Committee on the Recognition of Professional Qualifications,

HAS ADOPTED THIS REGULATION:

Article 1

Annexes II and V to Directive 2005/36/EC are amended as set out in the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the 20th day following its publication in the Official Journal of the European Union.

This Regulation shall be binding in its entirety and directly applicable in all Member States. Done at Brussels, 3 March 2011. For the Commission The President José Manuel Barroso

ANNEX

ANNEX

Annexes II and V to Directive 2005/36/EC are amended as follows:

1. in point 1 of Annex II, under in Austria, the following is added: which represents education and training courses of a total duration of at least 13 years and six months to 14 years, including at least 10 years’ general education, a further three years’ basic training in the upper-grade public service for healthcare and nursing, and six to 12 months’ special training in a specialised, teaching or management task.;

1. —

special training in the care of children and young people (Sonderausbildung in der Kinder- und Jugendlichenpflege),

special training in psychiatric healthcare and nursing (Sonderausbildung in der psychiatrischen Gesundheits- und Krankenpflege),

special training in intensive care (Sonderausbildung in der Intensivpflege),

special training in intensive care of children (Sonderausbildung in der Kinderintensivpflege),

special training in anaesthesia-related nursing (Sonderausbildung in der Anästhesiepflege),

special training in renal replacement therapy related nursing (Sonderausbildung in der Pflege bei Nierenersatztherapie),

special training in operating department nursing (Sonderausbildung in der Pflege im Operationsbereich),

special training in hospital hygiene (Sonderausbildung in der Krankenhaushygiene),

special training for teaching tasks in healthcare and nursing (Sonderausbildung für Lehraufgaben in der Gesundheits- und Krankenpflege),

special training for management tasks in healthcare and nursing. (Sonderausbildung für Führungsaufgaben in der Gesundheits- und Krankenpflege),

2. the following table is added to point 5.1.3 of Annex V: Country Medical oncology Minimum period of training: 5 years Medical genetics Minimum period of training: 4 years Title Title Belgique/België/Belgien Oncologie médicale/ Medische oncologie България Медицинска онкология Медицинска генетика Česká republika Klinická onkologie Lékařská genetika Danmark Klinisk genetik Deutschland Humangenetik Eesti Meditsiinigeneetika Ελλάς Παθολογική Ογκολογία España France Oncologie Génétique médicale Ireland Medical oncology Clinical genetics Italia Oncologia medica Genetica medica Κύπρος Ακτινοθεραπευτική Ογκολογία Latvija Onkoloģija ķīmijterapija Medicīnas ģenētika Lietuva Chemoterapinė onkologija Genetika Luxembourg Oncologie médicale Médecine génétique Magyarország Klinikai onkológia Klinikai genetika Malta Nederland Klinische genetica Österreich Medizinische Genetik Polska Onkologia kliniczna Genetyka kliniczna Portugal Oncologia médica Genética médica România Oncologie medicala Genetica medicala Slovenija Internistična onkologija Klinična genetika Slovensko Klinická onkológia Lekárska genetica Suomi/Finland Perinnöllisyyslääketiede/ Medicinsk genetik Sverige United Kingdom Medical oncology Clinical genetics

Versions

1. 2011-03-03

Cited by

• Council Decision of 19 July 2011 on the position to be taken by the European Union within the EU-Swiss Joint Committee established by Article 14 of the Agreement between the European Community and its Member States, of the one part, and the Swiss Confederation, of the other, on the free movement of persons, as regards the replacement of Annex III (Mutual recognition of professional qualifications) thereto (2011/467/EU) Decision · Grade B

  Commission Regulation (EU) No 213/2011 of 3 March 2011 amending Annexes II and V to Directive 2005/36/EC of the European Parliament and of the Council on the recognition of professional qualifications (OJ L 59, 4.3.2011, p. 4),